Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
Open Access
- 24 March 2021
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 36 (8) , 2473-2484
Abstract
Background: Non-HLA antibodies against endothelial targets have been implicated in the pathogenesis of antibody-mediated rejection (ABMR), but data in pediatric patients are scarce. Methods: We retrospectively analyzed a carefully phenotyped single-center (University Children’s Hospital Heidelberg, Germany) cohort of 62 pediatric kidney transplant recipients (mean age at transplantation, 8.6 ± 5.0 years) at increased risk of graft function deterioration. Patients had received their transplant between January 1, 1999, and January 31, 2010. We examined at time of late index biopsies (more than 1-year post-transplant, occurring after January 2004) the association of antibodies against the angiotensin II type 1 receptor (AT1R), the endothelin type A receptor (ETAR), the MHC class I chain-like gene A (MICA), and vimentin in conjunction with overall and complement-binding donor-specific HLA antibodies (HLA-DSA) with graft histology and function. Results: We observed a high prevalence (62.9%) of non-HLA antibody positivity. Seventy-two percent of HLA-DSA positive patients showed additional positivity for at least one non-HLA antibody. Antibodies against AT1R, ETAR, and MICA were associated with the histological phenotype of ABMR. The cumulative load of HLA-DSA and non-HLA antibodies in circulation was related to the degree of microinflammation in peritubular capillaries. Non-HLA antibody positivity was an independent non-invasive risk factor for graft function deterioration (adjusted hazard ratio 6.38, 95% CI, 2.11–19.3). Conclusions: Our data indicate that the combined detection of antibodies to HLA and non-HLA targets may allow a more comprehensive assessment of the patients’ immune responses against the kidney allograft and facilitates immunological risk stratification.Keywords
Funding Information
- Peter-Stiftung für die Nierenwissenschaft, Münster, Germany
This publication has 47 references indexed in Scilit:
- HLA and MICA: Targets of Antibody-Mediated Rejection in Heart TransplantationTransplantation, 2011
- The effect of MICA antigens on transplant outcomes: A systematic reviewJournal of Evidence-Based Medicine, 2011
- Involvement of functional autoantibodies against vascular receptors in systemic sclerosisAnnals of the Rheumatic Diseases, 2011
- Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative PatientsTransplantation, 2010
- Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant FailureAmerican Journal of Transplantation, 2009
- HLA-Specific Antibodies Developed in the First Year Posttransplant are Predictive of Chronic Rejection and Renal Graft LossTransplantation, 2009
- Identification of Epitopes and Immunodominant Regions on the MICA Protein Defined by Alloantibodies From Kidney Transplant PatientsTransplantation, 2009
- New Equations to Estimate GFR in Children with CKDJournal of the American Society of Nephrology, 2009
- Incidence and Prediction of Early Antibody-Mediated Rejection due to Non-Human Leukocyte Antigen-AntibodiesTransplantation, 2008
- Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implicationsArthritis & Rheumatism, 2001